Human Actin, (cytoplasmic 1) (NT) Antibody from EXALPHA BIOLOGICALS, INC.
Search, find, compare suppliers for anti-Human Actin, (cytoplasmic 1) (NT) antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | Human Actin, (cytoplasmic 1) (NT) |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human |
| Isotype | n/a |
| Format | antigen affinity purified |
| Size | 100 µg |
| Concentration | n/a |
| Applications | Western Blotting, Western Blotting, Immunohistochemistry |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Rabbit anti Human Actin, (cytoplasmic 1) (NT) |
| Immunogen | Synthetic peptide derived from the N-terminal of the beta-actin protein. |
| Other Names | n/a |
| Gene, Accession # | UniProt: P60709 |
| Catalog # | X2742P |
| Price | $319 |
| Order / More Info | Human Actin, (cytoplasmic 1) (NT) Antibody from EXALPHA BIOLOGICALS, INC. |
| Product Specific References | 1. Ponte P., Ng S.Y., Engel J., Gunning P., Kedes L., Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA. Nucleic Acids Res. 12:1687-1696(1984) 2. Nakajima-Iijima S., Hamada H., Reddy P., Kakunaga T.,Molecular structure of the human cytoplasmic beta-actin gene: interspecies homology of sequences in the introns. Proc. Natl. Acad. Sci. U.S.A. 82:6133-6137(1985) 3. Procaccio V., Salazar G., Ono S., Styers M.L., Gearing M., Davila A., Jimenez R., Juncos J., Gutekunst C.-A., Meroni G., Fontanella B., Sontag E., Sontag J.-M., Faundez V., Wainer B.H. A mutation of beta -actin that alters depolymerization dynamics is associated with autosomal dominant developmental malformations, deafness, and dystonia. Am. J. Hum. Genet. 78:947-960(2006) [PubMed: 16685646] [Abstract] |
EXALPHA BIOLOGICALS, INC.
EXALPHA BIOLOGICALS, INC.
2 Shaker Road, Unit B101
Shirley MA 01464
P: 978-425-1370
info@exalpha.com
https://www.exalpha.com
Profile of EXALPHA BIOLOGICALS, INC.
Return to Antibodies